INTEGRATED BIOPHARMA INC Annual Deferred Income Tax Expense (Benefit) in USD from 2011 to 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
Summary
Integrated Biopharma Inc quarterly/annual Deferred Income Tax Expense (Benefit) history and growth rate from 2011 to 2024.
  • Integrated Biopharma Inc Deferred Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was $197K, a 2363% increase year-over-year.
  • Integrated Biopharma Inc annual Deferred Income Tax Expense (Benefit) for 2024 was $125K, a 73.6% increase from 2023.
  • Integrated Biopharma Inc annual Deferred Income Tax Expense (Benefit) for 2023 was $72K.
  • Integrated Biopharma Inc annual Deferred Income Tax Expense (Benefit) for 2022 was -$1.53M, a 10.5% decline from 2021.
Deferred Income Tax Expense (Benefit), Annual (USD)
Deferred Income Tax Expense (Benefit), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $125K +$53K +73.6% Jul 1, 2023 Jun 30, 2024 10-K 2024-09-20
2023 $72K +$1.6M Jul 1, 2022 Jun 30, 2023 10-K 2024-09-20
2022 -$1.53M -$145K -10.5% Jul 1, 2021 Jun 30, 2022 10-K 2023-09-15
2021 -$1.39M -$36K -2.67% Jul 1, 2020 Jun 30, 2021 10-K 2022-09-13
2020 -$1.35M -$1.38M -4188% Jul 1, 2019 Jun 30, 2020 10-K 2021-09-02
2019 $33K -$223K -87.1% Jul 1, 2018 Jun 30, 2019 10-K 2020-09-23
2018 $256K +$1.08M Jul 1, 2017 Jun 30, 2018 10-K 2019-08-29
2017 -$823K -$937K -822% Jul 1, 2016 Jun 30, 2017 10-K 2018-09-12
2016 $114K +$345K Jul 1, 2015 Jun 30, 2016 10-K 2016-09-02
2015 -$231K +$191K +45.3% Jul 1, 2014 Jun 30, 2015 10-K 2016-09-02
2014 -$422K +$44K +9.44% Jul 1, 2013 Jun 30, 2014 10-K 2015-09-04
2013 -$466K -$1.64M -140% Jul 1, 2012 Jun 30, 2013 10-K 2014-09-08
2012 $1.17M +$818K +230% Jul 1, 2011 Jun 30, 2012 10-K 2013-09-30
2011 $356K Jul 1, 2010 Jun 30, 2011 10-K 2012-10-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.